References
- Olson J E, Janney C A, Rao R D, Cerhan J R, Kurtin P J, Schiff D, et al. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma. Cancer 2002; 95: 1504–1510
- Eby N L, Grufferman S, Flannelly C M, Schold S C, Jr, Vogel F S, Burger P C. Increasing incidence of primary brain lymphoma in the US. Cancer 1988; 62: 2461–2465
- Hardwidge C, Diengdoh J V, Husband D, Nash J R. Primary cerebral lymphoma—a clinico-pathological study. Clin Neuropathol 1990; 9: 217–223
- Miller D C, Hochberg F H, Harris N L, Gruber M L, Louis D N, Cohen H. Pathology with clinical correlations of primary central nervous system non-Hodgkins lymphoma. The Massachusetts General Hospital experience 1958 – 1989. Cancer 1994; 15: 1383–1397
- Nelson D F, Martz K L, Bonner H, Nelson J S, Newall J, Kerman H D, et al. Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 1992; 23: 9–17
- Fine H A, Mayer R J. Primary central nervous system lymphoma. Ann Intern Med 1993; 119: 1093–1104
- Schultz C, Scott C, Sherman W, Donahue B, Fields J, Murray K, et al. Pre-irradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06. J Clin Oncol 1996; 14: 556–564
- O'Neill B P, O'Fallon J R, Earle J D, Colgan J P, Brown L D, Krigel R L. Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy?. Int J Radiat Oncol Biol Phys 1995; 33: 663–673
- Hoang-Xuan K, Taillandier L, Chinot O, Soubeyran P, Bogdhan U, Hildebrand J, et al. Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group. J Clin Oncol 2003; 21: 2726–2731
- Abrey L E, Yahalom J, DeAngelis L M. Treatment for primary CNS lymphoma: the next step. J Clin Oncol 2000; 18: 3144–3150
- DeAngelis L M, Seiferheld W, Schold S C, Fisher B, Shultz C J. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. J Clin Oncol 2002; 20: 4643–4648
- Batchelor T, Carson K, O'Neill A, Grossman S A, Alavi J, New P, et al. Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07. J Clin Oncol 2003; 21: 1044–1049
- Wu H G, Kim I H, Ha S W, Park C I, Bang Y J, Huh D S. Survival improvement with combined radio-chemotherapy in the primary central nervous system lymphomas. J Korean Med Sci 1999; 14: 565–570
- O'Brien P, Roos D, Pratt G, Liew K, Barton M, Poulsen M, et al. Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma. J Clin Oncol 2000; 18: 519–526
- DeAngelis L M, Yahalom J, Thaler H T, Kher U. Combined modality therapy for primary CNS lymphoma. J Clin Oncol 1992; 10: 635–643
- Herrlinger U, Schabet M, Brugger W, Kortmann R D, Kuker W, Deckert M, et al. German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma. Ann Neurol 2002; 51: 247–252
- Sandor V, Stark-Vancs V, Pearson D, Nussenblatt R, Whitcup S M, Brouwers R, et al. Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma. J Clin Oncol 1998; 16: 3000–3006
- Freilich R J, Delattre J Y, Monjour A, DeAngelis L M. Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients. Neurology 1996; 50: 1934–1935
- Shenkier T N, Voss N, Chhanabhai M, Fairey R, Gascoyne R D, Hoskins P, et al. The treatment of primary central nervous system lymphoma in 122 immunocompetent patients. Cancer 2005; 103: 1008–1017
- Panageas K S, Elkin E B, DeAngelis L M, Ben-Porat L, Abrey L E. Trends in survival from Primary Central Nervous System Lymphoma, 1975 – 1999. Cancer 2005; 104: 2466–2472
- The NCCN 2006 Central Nervous System Cancers Clinical Practice Guidelines in Oncology © 2006 National Comprehensive Cancer Network, Inc. Jenkintown, PA. Available online at: http://www.nccn.org (accessed 18 April 2006)
- Ensuring Quality Cancer Care, M Hewitt, J V Simone. The National Academy Press, Washington, DC 1999
- Korfel A, Martus P, Nowrousian M R, Hossfeld D K, Kirchen H, Brucher J, et al. Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma. Br J Haematol 2005; 128: 177–183